{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:57:26Z","timestamp":1777633046741,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bcmd.2009.03.003","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T05:00:36Z","timestamp":1241326836000},"page":"88-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia"],"prefix":"10.1016","volume":"43","author":[{"given":"Ingo","family":"Roeder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"d'Inverno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2009.03.003_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2009.03.003_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1532\/IJH97.04054","article-title":"Imatinib mesylate in the treatment of chronic myelogenous leukemia","volume":"79","author":"Borthakur","year":"2004","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00432-003-0502-2","article-title":"Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia","volume":"130","author":"Deininger","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bcmd.2009.03.003_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1532\/IJH97.06024","article-title":"New strategies in chronic myeloid leukemia","volume":"83","author":"Kantarjian","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.leu.2401811","article-title":"Detection and quantification of residual disease in chronic myelogenous leukemia","volume":"14","author":"Hochhaus","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2009.03.003_bib6","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190500407996","article-title":"Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?","volume":"47","author":"Goldman","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2009.03.003_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hon.792","article-title":"Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukemia patients in treatment with imatinib as a guide to clinical management","volume":"24","author":"Martinelli","year":"2006","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.semcancer.2005.07.002","article-title":"Emergence and prevention of resistance against small molecule inhibitors","volume":"15","author":"Wodarz","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.bjc.6603310","article-title":"Mathematical models of targeted cancer therapy","volume":"95","author":"Abbott","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcmd.2009.03.003_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00109-007-0241-y","article-title":"Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia \u2014 insights from mathematical model analyses","volume":"86","author":"Roeder","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcmd.2009.03.003_bib12","first-page":"187","article-title":"Heterogeneity of hematopoietic stem cells: implications for clinical applications","volume":"107","author":"Morrison","year":"1995","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.bcmd.2009.03.003_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(00)80583-8","article-title":"Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells","volume":"96","author":"Morrison","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2009.03.003_bib14","first-page":"343","article-title":"Isolation and characterization of side population cells","volume":"290","author":"Goodell","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2005-05-2140","article-title":"SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity","volume":"107","author":"Yilmaz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01397280","article-title":"\u00dcber den anschaulichen Inhalt der quantentheoretischen Kinematik und Mechanik","volume":"43","author":"Heisenberg","year":"1927","journal-title":"Z. Phys."},{"key":"10.1016\/j.bcmd.2009.03.003_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1242\/dev.110.4.1001","article-title":"Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt","volume":"110","author":"Potten","year":"1990","journal-title":"Development"},{"key":"10.1016\/j.bcmd.2009.03.003_bib18","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"},{"key":"10.1016\/j.bcmd.2009.03.003_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the hematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the hematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.immuni.2006.11.005","article-title":"Maintaining hematopoietic stem cells in the vascular niche","volume":"25","author":"Kiel","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2009.03.003_bib22","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1110542","article-title":"Stem cells and their niches","volume":"311","author":"Moore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2009.03.003_bib23","first-page":"91","article-title":"Detection of functional hematopoietic stem cell niche using real-time imaging","volume":"457","author":"Xie","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.gt.3301717","article-title":"Cell fate determination from stem cells","volume":"9","author":"Wagers","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcmd.2009.03.003_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2353\/ajpath.2006.060312","article-title":"Hematopoietic stem cells: the paradigmatic tissue-specific stem cell","volume":"169","author":"Bryder","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcmd.2009.03.003_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.188.2.393","article-title":"The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit","volume":"188","author":"Habibian","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2009.03.003_bib28","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.V94.8.2548.420k38_2548_2554","article-title":"Reversible expression of CD34 by murine hematopoietic stem cells","volume":"94","author":"Sato","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib29","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1634\/stemcells.2007-0128","article-title":"Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation","volume":"25","author":"Aliotta","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2009.03.003_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature06965","article-title":"Transcriptome-wide noise controls lineage choice in mammalian progenitor cells","volume":"453","author":"Chang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/scd.2007.0195","article-title":"Conversion potential of marrow cells into lung cells fluctuates with cytokine-induced cell cycle","volume":"17","author":"Dooner","year":"2008","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bcmd.2009.03.003_bib32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2009.03.003_bib33","series-title":"Stem Cells","first-page":"1","article-title":"Stem cells and cellular pedigrees \u2014 a conceptual introduction","author":"Loeffler","year":"2007"},{"key":"10.1016\/j.bcmd.2009.03.003_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000057688","article-title":"Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models \u2014 a conceptual approach","volume":"171","author":"Loeffler","year":"2002","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.bcmd.2009.03.003_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(02)00832-9","article-title":"A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity","volume":"30","author":"Roeder","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)81691-8","article-title":"Stem cells: a new lease on life","volume":"100","author":"Fuchs","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2009.03.003_bib37","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/sj.emboj.7600223","article-title":"Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells","volume":"23","author":"Kosodo","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2009.03.003_bib38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ceb.2005.10.005","article-title":"Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system","volume":"17","author":"Huttner","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance","volume":"145","author":"Kantarjian","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2009.03.003_bib40","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2005-03-1240","article-title":"The kinetics of clonal dominance in myeloproliferative disorders","volume":"106","author":"Catlin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nm1487","article-title":"Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications","volume":"12","author":"Roeder","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2009.03.003_bib42","doi-asserted-by":"crossref","unstructured":"M.W. Drummond, N. Heaney, J. Kaeda, F.E. Nicolini, R.E. Clark, G. Wilson, P. Shepherd, J. Tighe, L. McLintock, T. Hughes, T.L. Holyoake, A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response. Leukemia (in press), doi: 10.1038\/leu.2009.43.","DOI":"10.1038\/leu.2009.43"},{"key":"10.1016\/j.bcmd.2009.03.003_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukemia","volume":"435","author":"Michor","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib44","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","article-title":"Successful therapy must eradicate cancer stem cells","volume":"24","author":"Dingli","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2009.03.003_bib45","doi-asserted-by":"crossref","first-page":"14931","DOI":"10.1073\/pnas.0607006103","article-title":"The age incidence of chronic myeloid leukemia can be explained by a one-mutation model","volume":"103","author":"Michor","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2009.03.003_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000118786","article-title":"Mathematical modeling of genesis and treatment of chronic myeloid leukemia","volume":"188","author":"Horn","year":"2008","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.bcmd.2009.03.003_bib47","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1007\/s11538-008-9336-z","article-title":"A PDE model for imatinib-treated chronic myelogenous leukemia","volume":"70","author":"Kim","year":"2008","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib48","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of BCR-ABL fusion genes in leukocytes of normal individuals: implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib49","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","article-title":"Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals","volume":"86","author":"Biernaux","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib50","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4238\/vol7-3gmr486","article-title":"Leukemia\/lymphoma-associated gene fusions in normal individuals","volume":"7","author":"Brassesco","year":"2008","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bcmd.2009.03.003_bib51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjc.6603604","article-title":"The long-term response to imatinib treatment of CML","volume":"96","author":"Michor","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcmd.2009.03.003_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib53","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1634\/stemcells.2007-0250","article-title":"Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources","volume":"25","author":"Graham","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcmd.2009.03.003_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2\u00a0years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2174\/156800906779010209","article-title":"Mechanisms of resistance to imatinib in CML patients: a paradigm for the advantages and pitfalls of molecularly targeted therapy","volume":"6","author":"Ritchie","year":"2006","journal-title":"Curr. Cancer Drug Targets."},{"key":"10.1016\/j.bcmd.2009.03.003_bib56","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.0501870102","article-title":"Drug resistance in cancer: principles of emergence and prevention","volume":"102","author":"Komarova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2009.03.003_bib57","first-page":"2205","article-title":"Resistance to tumor specific therapy with imatinib by clonal selection of mutated cells","volume":"127","author":"Muller","year":"2002","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.bcmd.2009.03.003_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cncr.20742","article-title":"Granulocyte\u2013colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia","volume":"103","author":"Jorgensen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2009.03.003_bib59","article-title":"IFN\u03b1 activates dormant HSCs in vivo","author":"Esser","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2009.03.003_bib60","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","article-title":"BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors","volume":"111","author":"Copland","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.leu.2403186","article-title":"Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity","volume":"18","author":"Mailander","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2009.03.003_bib62","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1073\/pnas.0405884101","article-title":"Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression","volume":"101","author":"Oka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2009.03.003_bib63","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/leu.2008.161","article-title":"Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy","volume":"22","author":"Yong","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2009.03.003_bib64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","article-title":"Leukemia-associated antigen specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies","volume":"111","author":"Rezvani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib65","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2007-12-128397","article-title":"Development and dynamics of robust T-cell responses to CML under imatinib treatment","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.03.003_bib66","doi-asserted-by":"crossref","first-page":"e1000095","DOI":"10.1371\/journal.pcbi.1000095","article-title":"Dynamics and potential impact of the immune response to chronic myelogenous leukemia","volume":"4","author":"Kim","year":"2008","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tpb.2007.08.003","article-title":"Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer","volume":"72","author":"Komarova","year":"2007","journal-title":"Theor. Popul. Biol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.exphem.2004.02.013","article-title":"A phase space model of hemopoiesis and the concept of stem cell renewal","volume":"32","author":"Kirkland","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2009.03.003_bib69","series-title":"Understanding Agent Systems","author":"d'Inverno","year":"2004"},{"key":"10.1016\/j.bcmd.2009.03.003_bib70","unstructured":"M. d'Inverno, P. Howells, S. Montagna, et al., Agent-based Modelling of Stem Cells, in: A.M. Uhrmacher (ed.), Multi-Agent Systems: Simulation and Applications, Taylor & Francis Group, London (in press)."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997960900062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997960900062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:26:54Z","timestamp":1761049614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997960900062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S107997960900062X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.03.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009  Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}